Concepedia

Author

Helen Huang

Roswell Park Comprehensive Cancer Center

Also Known As

H. Huang, H. Q. Huang, H.Q. HUANG, H.Q. Huang, Helen Huang, Helen Q Huang, Helen Q. Huang

103

Publications

13.4K

Citations

38

H-Index

45

Concepts

All Affiliations

Roswell Park Comprehensive Cancer CenterUniversity of California, IrvineGynecologic Oncology GroupUniversity of OklahomaNRG Oncology
HH

About

Helen Huang is an author at Roswell Park Comprehensive Cancer Center specializing in gynecology oncology, oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

29

2.8K

2

Health Sciences

9

9

1K

3

Public Health

8

8

261

4

Gastroenterology

1

1

20

5

Health Policy

1

1

25

Helen Huang

×

53

Publications

13K

Citations

37

H-Index

YearCitations

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel,

New England Journal of Medicine

2006

2.6K

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

Robert A. Burger, Mark F. Brady, Michael A. Bookman,

New England Journal of Medicine

2011

2.3K

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Krishnansu S. Tewari, Michael W. Sill, Harry J. Long,

New England Journal of Medicine

2014

1.5K

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson,

The Lancet

2017

656

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Robert L. Coleman, Mark F. Brady, Thomas J. Herzog,

The Lancet Oncology

2017

585

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro,

Journal of Clinical Oncology

2019

461

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

Daniela Matei, Virginia L. Filiaci, Marcus E. Randall,

New England Journal of Medicine

2019

444

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

John K. Chan, Mark F. Brady, Richard T. Penson,

New England Journal of Medicine

2016

355

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

Robert L. Coleman, Nick M. Spirtos, Danielle Enserro,

New England Journal of Medicine

2019

324

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

Joan L. Walker, Deborah K. Armstrong, Helen Huang,

Gynecologic Oncology

2005

319

Page 1